维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

13篇 您的检索式：作者名="Pereson"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Diffusion kurtosis imaging to detect amyloidosis in an APP/ PSI mouse model for Alzheimer's disease显示文摘	Vanhoutte G Pereson S Delgado Y Palacios R	2013	Magn Reson Med2013，69，4：	1
	2	Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models显示文摘	Pereson S Wils H Kleinberger G	2009	Journal of Pathology2009，219，2：	1
	3	Cutting edge:a new tool to evaluate human pre-erythrocytic malaria vaccines:rodent parasites bearing a hybrid Hasmodium falciparum circumsporozoite protein显示文摘	Pereson C Oliveira GA Sultan AA		0，，12：	1
	4	The use of isoxymc analysis in fungal taxonomy and genetics 显示文摘	Micales J A Boade M R Pereson G L	1986	Mycotaxon1986，27，：	1
	5	The use of isozyme analysis for the identification of plant pathogenic fungi显示文摘	Bonde M R Micales J A Pereson G L	1993	Plant Disease1993，77，：	1
	6	Diffusion kurtosis imaging to detect amyloidosis in an APP/PS1 mouse model for Alzheimer's disease 显示文摘	Vanhoutte G Pereson S Delgado YPR	2013	Magn Reson Med2013，69，4：	1
	7	Diffusion kurtosis imaging to detect amyloidosis in an APP/PS1 mouse model for Alzheimer's disease显示文摘	Vanhoutte G Pereson S Delgado YPR	2013	Magn Reson Med2013，69，：	1
	8	Diffusion kurtosis imaging to detect amyloidosis in an APP/PS1 mouse model for Alzheimer' s disease显示文摘	Vanhoutte G Pereson S Delgado Y	2013	Magn Reson Med2013，69，4：	1
	9	The use of isozyme analysis for the identification of plant pathogenic fungi显示文摘	BONDE M R MICALES J A PERESON G L	1993	Plant Disease1993，77，：	1
	10	The use of isozyme analysis in fungal taxonomy and genetics显示文摘	MICALES J A BONDE M R PERESON G L	1986	Mycotaxon1986，27，：	1
	11	Cellular ageing, increased mortality and FTLD- TDP-associated neuropathology in progranulin knockout mice 显示文摘	Wils H Kleinberger G Pereson S et ol	2012	J Pathol2012，228，1：	1
	12	Health related quality oflife in COPD ? why both disease specific and genericmeasures shouldbe used显示文摘	Engstrom CP Pereson LO Larsson S	2001	EurRespir J2001，18，1：	1
	13	Hepatitis C virus treatment failure:Clinical utility for testing resistance-associated substitutions显示文摘The hepatitis C virus has a high mutation capacity that leads to the emergence of resistance-associated substitutions(RAS).However,the consequence of resistance selection during new direct-acting antiviral drug(DAA)treatment is not necessarily the therapeutic failure.In fact,DAA treatment has shown a high rate(>95%)of sustained virological response even when high baseline RAS prevalence has been reported.In the context of RAS emergence and high rates of sustained viral response,the clinical relevance of variants harboring RAS is still controversial.Therefore,in order to summarize the data available in international guidelines,we have reviewed the clinical utility of testing RAS in the era of new pangenotypic DAA drugs.	Ezequiel Ridruejo Matias Javier Pereson Diego M Flichman Federico Alejandro Di Lello	2021	World Journal of Hepatology2021，13，9：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费